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Abstract
Background: Many epidemiological studies have shown that mass concentrations of ambient
particulate matter (PM) are associated with adverse health effects in the human population. Since
PM is still a very crude measure, this experimental study has explored the role of two distinct size
fractions: ultrafine (<0.15 µm) and fine (0.15- 2.5 µm) PM. In a series of 2-day inhalation studies,
spontaneously hypersensitive (SH) rats were exposed to fine, concentrated, ambient PM (fCAP) at
a city background location or a combination of ultrafine and fine (u+fCAP) PM at a location
dominated by traffic. We examined the effect on inflammation and both pathological and
haematological indicators as markers of pulmonary and cardiovascular injury. Exposure
concentrations ranged from 399 µg/m3 to 3613 µg/m3 for fCAP and from 269µg/m3 to 556 µg/m3
for u+fCAP.
Results: Ammonium, nitrate, and sulphate ions accounted for 56 ± 16% of the total fCAP mass
concentrations, but only 17 ± 6% of the u+fCAP mass concentrations. Unambiguous particle uptake
in alveolar macrophages was only seen after u+fCAP exposures. Neither fCAP nor u+fCAP
induced significant changes of cytotoxicity or inflammation in the lung. However, markers of
oxidative stress (heme oxygenase-1 and malondialdehyde) were affected by both fCAP and u+fCAP
exposure, although not always significantly. Additional analysis revealed heme oxygenase-1 (HO-1)
levels that followed a nonmonotonic function with an optimum at around 600 µg/m3 for fCAP. As
a systemic response, exposure to u+fCAP and fCAP resulted in significant decreases of the white
blood cell concentrations.
Conclusion: Minor pulmonary and systemic effects are observed after both fine and ultrafine +
fine PM exposure. These effects do not linearly correlate with the CAP mass. A greater component
of traffic CAP and/or a larger proportion ultrafine PM does not strengthen the absolute effects.
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Background
Epidemiological studies have shown that exposure to
ambient particulate air pollution (particulate matter or
PM) is associated with many health effects [1-3], which
include premature death, increased hospitalization for
cardiopulmonary diseases, airway complaints, and
reduced lung function. Although estimates of relative risks
are small, there is a public-health concern because many
people are exposed and there are high-risk groups, such as
the elderly, very young children, and people with cardiop-
ulmonary diseases. Although the PM-associated adverse
health effects have been found all over the world, a more
closer look reveals that there seem to be heterogeneous
across locations [4-8], which might be due to differences
of anthropogenic sources such as traffic [9]. Particulate
matter consists of many chemicals, but it is not very likely
that some of them (sea salt, sulphate, and nitrate [10] in
ambient air affect health adversely. Aerosolized combus-
tion products from traffic, shipping, industry, and domes-
tic heating are believed to be far more relevant. The risk
can be effectively reduced by reducing the PM fraction that
is most likely to cause adverse health effects.
Due to its the complexity, the best way to study PM is by
studying the effects of inhaling it. Systems designed to
deliver controlled amounts of concentrated ambient par-
ticles now exist and allow a mechanistic approach to
determining the effect of inhaled PM in different size
ranges [11-13]. Recently published studies have shown
that exposing rodents [14-20], dogs [21] and human vol-
unteers [22-26] to concentrated ambient particles (CAP)
indicate that PM has the potential to cause adverse effects.
Biological responses to high concentrations of PM (which
were often well above ambient PM concentrations) were
observed. The sensitivity of these toxicological studies is
low because of the small number of observations, as well
as the fact that exposure levels and PM composition vary
from day to day. However, data from homogeneous pop-
ulations, as well as the use of specific disease models that
mimic human risk groups, should increase study sensitiv-
ity to the effects of CAP exposures. The results of a series
of 1-day (6 h/day) inhalation exposures of compromised
rats to fCAP [27] revealed that CAP can increase inflam-
mation [polymorphonuclear leukocytes (PMNs)] and tox-
icity [protein and albumin in bronchoalveolar lavage
fluid (BALF)], and it can also increase the risk of throm-
botic vascular disorders (fibrinogen). Nonetheless, we
were unable to prove consistent relationships between PM
mass and biological effects. While alterations of biological
endpoints were occasionally statistically significant and
potentially biologically relevant, we found no convincing
proof that ambient PM exposures (up to 3500 µg/m3) can
modify homeostasis. In another study in which rats pre-
treated with ozone or with induced pulmonary hyperten-
sion were exposed for 6 h to concentrated freshly gener-
ated diesel exhaust particles up to 9000 µg/m3, no
noteworthy pulmonary toxicity was observed, though
increased glutathione levels (in the case of ozone-treated
rats) and increased blood fibrinogen levels in rats with
existing pulmonary hypertension were observed [20].
Although these studies and those of others [14,15] have
shown that CAP exposure has adverse effects, no studies
have yet been published that convincingly prove relation-
ships between mass concentration and these biologically
relevant outcomes [18,27]. Bearing the available evidence
of studies exposing animal or human subjects to CAP, PM
mass concentrations do not seem to be the optimal metric
to be associated with the adverse health effects. In that
respect it is noteworthy that monotonic functions are usu-
ally sufficient to describe the relationship between air pol-
lution and health effects in the epidemiological studies.
However, Seagreave and colleagues [28] have recently
shown that at least some parameters may respond in a
way that achieves an optimum concentration beyond
which the effects are reduced again.
Most toxicological studies that have used CAP exposures
have focused on the accumulation mode (0.15 µm – 2.5
µm) [15,17,19] or coarse mode (2.5 µm – 10 µm) [17] of
ambient PM. In recent years, more and more information
has shown that the ultrafine fraction within PM might be
more toxic than the fine mode. It has been suggested that
the large surface area or particle number, or perhaps just
the particle size, may play an important role in such dif-
ferential responses [29,30]. Other studies have shown that
the ultrafine fraction of urban ambient aerosols is not nec-
essarily more potent than the fine or coarse fractions in
inducing inflammatory and toxic effects in lung cells [31].
In order to compare the potential of PM fractions to
induce adverse biological effects, we performed a series of
studies of spontaneously hypertensive (SH) rats in which
we used both concentrated fine PM (fCAP) and ultrafine
+ fine PM (u+fCAP). We compared the effects of PM that
included ultrafines at a site with traffic as the major source
with toxicity of accumulation mode (fine PM) at an urban
background site with no dominant source of PM emis-
sion. A strain of SH rats was selected as a strain that would
be more sensitive to PM [19] and to allow interstudy com-
parison [27,15].
Results
Exposure characteristics
Integrated and continuous exposure characterization
techniques were applied to determine the concentration
and the composition of the test atmospheres at the differ-
ent exposures (Table 1). Temperature and relative humid-
ity were 22 ± 2°C and 40 ± 10% for the fCAP exposure and
both control exposures; they were 22 ± 2°C and 70 ± 10%
for the u+fCAP exposure. The mean overall levels of someParticle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
Page 3 of 14
(page number not for citation purposes)
gaseous pollutants before passing the air through the con-
centrator were: 12 µg/m3 for ozone, 39 µg/m3 for carbon
monoxide, 29 µg/m3 for sulphur dioxide, 19 µg/m3 for
nitrogen monoxide, 13 µg/m3 for nitrogen dioxide and 28
µg/m3 for total nitrogen oxides (NOx). Ambient ozone is
known to be efficiently removed in the concentrator due
to the large metal surface, whereas all other gaseous com-
ponents will remain at the same concentration or will
show a little decrease. Table 1 shows that the sum of
ammonium, nitrate, and sulphate ions accounts for 56 ±
16% of the total fCAP mass concentrations for the
Bilthoven site (I), whereas it only accounts for 17 ± 6% of
the u+fCAP mass concentrations at the HIA site (II). Most
of the remaining mass is very likely associated with car-
bonaceous material, and the difference between site I and
site II reflects the enrichment in organic and elemental
carbon, as expected, given its proximity to mobile sources.
Bronchoalveolar lavage
Table 2 presents the overall results of the BALF biochemi-
cal analyses. The contribution to the day-to-day variation
was calculated in a two-way ANOVA for the biological
indices of both the filtered air and the CAP- exposed ani-
mals. Some of the parameters showed substantial day-to-
day differences that might be attributed to the assays and
need to be taken into account as a confounding factor in
the overall statistical analysis. The CAP exposures, with
either the combined fCAP exposures (at site I Bilthoven)
or the combined u+fCAP exposures (at site II HIA) did not
result in statistically significant changes of most biochem-
ical analyses measured in BALF compared to their filter-air
controls. No signs of cytotoxicity as indicated by
unchanged LDH and ALP levels were observed. No signif-
icant changes were found either in the number of cells or
cell differentiation in the BALF. However, clear particle
uptake was observed in macrophages lavaged from the rat
lungs after exposure to fCAP or u+fCAP. MDA, a parame-
ter for lipid peroxidation, is significantly lowered by
u+fCAP exposures (Table 2).
Levels of the overall HO-1 values in BALF, as a measure for
oxidative stress in the lungs, were increased by u+fCAP
Table 1: Exposure characteristics for studies in spontaneously hypertensive rats exposed to concentrated ambient particulate matter
Exposu
re
fCAP (Site I = Bilthoven) u+fCAP (Site II = HIA)
Date 6-1-03 13-1-
03
20-1-
03
27-1-
03
11-2-
03
8-7-03 29-9-
03
6-10-
03
13-10-
03
4-10-
04
6-10-
04
11-10-
04
13-10-
04
Mass1) µg/m3 1067.5 456.5 399.0 609.5 3613.0 269.0 409.0 366.5 379.0 501.2 448.2 555.8 534.7
Diamet
er2)
µm 0.65 0.74 0.71 0.75 0.71 0.68 0.72 0.75 0.67 1.09 1.41 0.58 1.08
gsd2) 1.14 1.34 1.35 1.30 1.17 1.32 1.33 1.56 1.35 0.21 0.28 0.25 0.22
Numbe
r 
counts2
)
320,00
0
470,00
0
66,000 45,000 998,75
0
1,310,3
20
1,624,0
00
1,282,0
00
Compounds3)
SO4
2-
µg/m3 240 86 63 98 908 19 27 25 17 14 28 26 41
NO
3
-
µg/m3 3 4 9 8 66 61 1 2 8 6 0 1 63 71 63 73 35 03 35 3
NH
4
+
µg/m3 1 9 4 5 34 06 86 8 4 8 1 81 02 29 1 71 12 5
Cl- µg/m3 22 51 42 96 65 38 33 45 35 1 1 1 1
Gases4)
O3 µg/m3 22 16 22 22 10 nm nm nm nm 10 0 0 0
CO µg/m3 32 42 32 31 48 nm nm nm nm 39 40 41 37
SO2 µg/m3 40 42 36 26 12 nm nm nm nm 6 14 14 13
NO µg/m3 65556n m n m n m n m 2 8 3 2 5 0 2 7
NO
2
µg/m3 9 1 1 9 9 2 1 n mn mn mn m1 7 1 9 1 5 1 7
NO
x
µg/m3 10 12 9 9 13 nm nm nm nm 41 45 55 41
Experiments A-E concentrated PM in size range of 0.15–2.5 µm, F-N in size range <2.5µm including PM<0.15 µm. fCAP, fine concentrated ambient 
particulate matter; u+fCAP, ultrafine plus fine concentrated ambient particulate matter
1) Time-integrated 2-day mean mass concentrations at the outlet of the particle concentrator
2) Diameter, gsd (geometric standard deviation) and number are measured by an aerodynamic particle sizer which measures only particles larger 
than 0.5 µm. Results are based on numbers
3) Chemical analyses (ion chromatography) of filter used for mass concentration
4) nm, not measuredParticle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
Page 4 of 14
(page number not for citation purposes)
and fCAP exposures (after omitting data of the two exper-
iments with the highest exposure concentrations, e.g. Jan-
uary 6th 2003 and February 11 2003) (Table 2). For the
u+fCAP exposure, there was a significant increase to 0.664
ng/ml compared to the 0.517 ng/ml value of the control
animals. However, more detailed data analyses of the
fCAP data shows a clear nonmonotonic concentration-
effect relationship with the HO-1. Maximum levels of
HO-1 were observed at around 600 µg/m3 measured both
in BALF and in lung homogenate (Figure 2). There is a cor-
relation of r2= 0.79 for the HO-1 measured in BALF and in
lung homogenate (Figure 3). Data corrected for the
amount of protein present were very comparable to Figure
2 (data not shown). In none of the fCAP exposures did the
LDH content in BALF change significantly upon exposure.
The only other parameter which showed significance at
the individual fCAP exposures was CC16, which was sig-
Table 2: Health effect parameters measured in lung lavage fluid of spontaneously hypertensive rats 8 h afterexposure to concentrated 
ambient particulate matter or clean air as a control.
fCAP (Site I) u+fCAP (Site II)
Control (n = 40) CAPs (n = 40) Control (n = 64) CAPs (n = 64)
Parame
ter
Units Mean 95% CI Mean 95% CI Sign. Mean 95% CI Mean 95% CI Sign.
ALP U/L 57.0 52.0–62.1 51.6 44.9–58.3 26.7 23.4–30.0 26.1 22.9–29.2
LDH U/L 66.3 62.2–70.4 67.6 63.3–72.0 55.7 49.5–61.9 52.5 50.3–54.8
Protein mg/L 314 277.9–
350.4
349 295.5–
402.2
274.5 242–308 282.0 256–288
NAG U/L 1.31 1.20–1.43 1.43 1.32–1.54 0.79 0.70–0.87 0.81 0.74–0.88
UA-B umol/L 0.29 0.22–0.35 0.45 0.26–0.63 0.46 0.36–0.56 0.42 0.34–0.51
Total 
Glut.
umol/L 0.92 0.789–
1.058
1.00 0.836–
1.165
1.34 1.02–1.65 1.22 1.12–1.31
GSH umol/L 0.155 0.099–
0.211
0.244 0.158–
0.329
0.39 0.21–0.57 0.31 0.22–0.40
GSSG:G
SH
ratio 2.61 1.70 4.8 2.7
TNF-α  ng/ml 46.4 42.5–50.2 47.7 43.2–52.1 45.9 37.6–54.2 46.4 37.9–54.9
MIP-2 ng/ml 333 321–344 311 297–325 192.4 183–202 192.2 184–200 a
IL-1b ng/ml 268 237–299 248 210–286 n.m. n.m.
CC16 ng/ml 1.78 1.41–2.14 1.98 1.56–2.40 3.31 3.31
MDA µmol/l 0.268 0.200–
0.335
0.237 0.201–
0.273
0.407 0.341–
0.473
0.341 0.281–
0.401
*
HO-1 ng/ml 0.393 0.296–
0.491
0.521 0.347–
0.696
0.517 0.418–
0.615
0.664 0.547–
0.781
**
Macrop
hages
% 90.5 89.2–91.8 88.7 87.2–90.1 94.4 93.1–95.6 94.2 93.0–95.3
Neutrop
hils
% 4.95 3.70–6.20 4.76 3.54–5.99 1.95 1.26–2.64 1.95 1.37–2.54
Eosinop
hils
% 0.60 0.44–0.76 0.44 0.28–0.61 0.42 0.23–0.61 0.34 0.21–0.46
Lymfocy
tes
% 1.05 0.83–1.27 1.43 1.08–1.77 2.60 1.93–3.28 2.99 2.11–3.88
Cell 
count
*10e3 541 481–600 528 473–583 469 381–556 417 349–485
Macrop
hages
*10e3 489 435–543 461 415–507 445 358–532 394 327–461
Neutrop
hils
*10e3 25.70 17.2–34.2 26.80 17.8–35.9 7.88 4.36–
11.41
7.39 5.23–9.52
Eosinop
hils
*10e3 3.04 2.24–3.84 2.60 1.47–3.73 2.02 0.73–3.31 1.46 0.80–2.11
Lymfocy
tes
*10e3 5.50 4.20–6.84 7.70 5.60–9.81 P = 0.06 10.41 7.43–
13.40
11.87 8.01–
15.73
**p < 0.01
an = 32
ALP, alkaline phosphatase; LDH, lactate dehydrogenase; NAG, N-acetyl glucosaminidase; UA, uric acid, Total Glut., total glutathione; GSH, reduced 
glutathione;GSSG, oxidized glutathione; TNF-α, tumor necrotic factor; MIP, macrophage inhibiting factor;IL, interleukine, CC16, Clara cell protein; 
MDA, malondialdehyde; HO-1, heme oxygenase; CI, confidence interval; fCAP, fine concentrated ambient particulate matter; n.m., not measured; 
u+fCAP, ultrafine plus fine concentrated ambient particulate matter.Particle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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nificantly decreased at 457 µg/m3 fCAP and increased at
the greatest exposure of 3613 µg/m3 fCAP (Figure 4).
Blood
After exposure to fCAP and u+fCAP, there was a signifi-
cant decrease of WBCs (Table 3). Consequently, absolute
numbers of neutrophils and lymphocytes are decreased
(although the decrease is not statistically significant for
the number of neutrophils after u+fCAP exposure). Signif-
icant changes in haematological parameters, i.e., the
mean platelet volume (MPV) and the mean platelet com-
ponent (MPC), were found after exposure to u+fCAP, but
these effects are not observed for the fCAP-exposed rats
(the MPC parameter has not been measured for the fCAP
exposures). No changes in concentrations of fibrinogen
and vWF were observed in plasma after exposure to
u+fCAP or fCAP. However, a significant increase of the
greatest concentration of the fCAP exposure was observed
for vWF (Figure 5).
Von Willebrand factor present in citrate plasma after rats  were exposed to fine, concentrated, ambient particulate mat- ter (fCAP) (site I)   control, ■  fCAP exposed Figure 5
Von Willebrand factor present in citrate plasma after rats 
were exposed to fine, concentrated, ambient particulate mat-
ter (fCAP) (site I)   control, ■  fCAP exposed.
Schematic representation of the study design Figure 1
Schematic representation of the study design. Animals were exposed to concentrated ambient particulate matter on day 1 and 
2. Necropsy took place 18 h after exposure. SHR, spontaneously hypertensive rat.
Relative heme oxygenase-1 present in bronchoalveolar lavage  fluid ( ) and in lung homogenate ( ) versus the mass of  fine, concentrated, ambient particulate matter Figure 2
Relative heme oxygenase-1 present in bronchoalveolar lavage 
fluid ( ) and in lung homogenate ( ) versus the mass of 
fine, concentrated, ambient particulate matter. Relative heme 
oxygenase-1 is defined as ([HO-1]CAP- [HO-1]Control)/[HO-
1]Control, where [HO-1] is the mean value of n = 8.Particle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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Table 3: Health effect parameters measured in blood of spontaneously hypertensive rats 8 h after exposure to concentrated ambient 
particulate matter or clean air as a control.
fCAP (Site I) u+fCAP (Site II)
Control (n = 40) CAP (n = 40) Control (n = 32) CAP (n = 32) Variation 
among
Control 
(n = 40)
CAP (n 
= 40)
Marker Units Mean 95% CI Mean 95% CI Statistica
l 
significan
ce
95% CI Mean 95% CI experim
ents
WBC * e9/L 3.20 3.01–
3.38
2.89 2.68–
3.10
* 3.82 3.61–
4.02
3.51 3.31–
3.72
** * *
RBC * e12/L 8.67 8.59–
8.76
8.74 8.66–
8.82
8.88 8.78–
8.97
8.94 8.86–
9.03
***
HGB mmol/L 8.69 8.60–
8.77
8.75 8.67–
8.82
8.66 8.56–
8.76
8.69 8.60–
8.78
***
HCT L/L 0.404 0.400–
0.408
0.408 0.404–
0.412
* 0.42 0.410–
0.419
0.42 0.411–
0.418
***
MCV fL 46.61 46.22–
46.99
46.74 46.35–
47.14
46.72 46.53–
46.91
46.33 46.13–
46.53
**
MCH fmol 1.002 0.994–
1.010
1.002 0.995–
1.010
0.98 0.971–
0.980
0.97 0.967–
0.976
**
MCHC mmol/L 21.50 21.42–
21.58
21.42 21.35–
21.50
20.90 20.82–
20.94
20.97 20.90–
21.04
** * *
RDW % 11.83 11.69–
11.98
11.68 11.55–
11.80
11.64 11.53–
11.76
11.67 11.51–
11.82
HDW mmol/L 1.44 1.411–
1.4778
1.44 1.408–
1.474
1.52 1.506–
1.539
1.53 1.515–
1.544
*
PLT * e9/L 942 913–972 929 899–959 992 964–
1019
992 946–
1038
***
MPV fL 7.39 7.29–
7.50
7.38 7.31–
7.46
7.10 7.01–
7.19
7.24 7.16–
7.32
*** ***
MPC 23.30 23.06–
23.56
23.86 23.61–
24.11
a *** ***
Reticul
o-
abs 75.8 71.3–
80.4
72.0 66.6–
77.5
75.8 71.3–
80.4
72.0 66.6–
77.5
cytes % 0.87 0.77–
0.96
0.71 0.64–
0.78
* 0.86 0.815–
0.92
0.81 0.75–
0.87
*
Neutro
phils
abs 0.42 0.39–
0.46
0.33 0.31–
0.36
*** 0.51 0.47–
0.55
0.47 0.44–
0.52
*
Lymph
ocytes
abs 2.65 2.48–
2.83
2.45 2.26–
2.65
* 3.13 2.96–
3.30
2.87 2.69–
3.04
** ***
Monocy
tes
abs 0.075 0.067–
0.083
0.0687 0.060–
0.077
0.103 0.092–
0.114
0.098 0.0869–
0.109
***
Eosino
phils
abs 0.0262 0.023–
0.029
0.0262 0.022–
0.029
0.013 0.0073–
0.0190
0.013 0.0098–
0.0165
***
Basoph
ils
abs 0.00498 0.00347
–
0.00649
0.00517 0.00381
–
0.00653
0.060 0.0496–
0.0699
0.062 0.0506–
0.0736
***
LUC abs 0.0129 0.0109–
0.0149
0.0119 0.0100–
0.0137
0.008 0.0043–
0.0107
0.009 0.0054–
0.0117
***
Neutro
phils
% 13.54 12.21–
14.88
11.90 10.82–
12.98
* 13.37 12.55–
14.20
13.48 12.44–
14.51
Lymph
ocytes
% 82.62 81.22–
84.02
84.23 83.11–
85.36
* 81.90 80.98–
82.76
81.40 80.23–
82.58
Monocy
tes
% 2.39 2.14–
2.63
2.33 2.15–
2.52
2.66 2.46–
2.87
2.72 2.51–
2.93
***
Eosino
phils
% 0.836 0.754–
0.918
0.935 0.823–
1.048
0.340 0.204–
0.475
0.353 0.276–
0.430
***
Basoph
ils
% 0.203 0.169–
0.236
0.192 0.161–
0.223
1.550 1.33–
1.79
1.790 1.47–
2.12
***Particle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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Pathology
There were no differences in the lung and body weights of
sham and CAP-exposed animals (data not shown). The
characteristic hallmarks of the strain of rats used as con-
trols were clearly present in their lungs: small alveolar
haemorrhages and extensive bronchus-associated lym-
phoid tissue (BALT) at many bifurcations of the airways.
These signs were not affected by the CAP exposures (Table
4).
No noticeable pathological changes could be observed for
either the fCAP or the u+fCAP exposure. Deposition of
PM was noted in most of the animals exposed to u+fCAP
(52 of 64). This was not observed for animals exposed to
fCAP only. Groups of alveolar macrophages were present
in nearly all CAP-exposed animals, as in controls.
The lymphocytes in the BALT areas and the perivascular
infiltrate of all SH rats were fairly strongly labelled as
noted by BrdU incorporation in the DNA, and there was a
slight labelling in the alveolar area, which reflects the
background turnover. There was slightly more BrdU label-
ling in all components of those areas of the H&E slides
where inflammatory foci were present: an increased pro-
liferation rate in the bronchiolar and alveolar epithelium,
as well as in alveolar macrophages. No change of cell pro-
liferation was seen from the labelling-frequency data of
nuclei in the control and CAP-exposed groups, and there
were no differences between u+fCAP and fCAP groups in
this respect (Table 4). The number of foci detected by the
immunocytochemical BrdU procedure runs nearly paral-
lel to the observed inflammatory foci with thickened septa
in the H&E-stained sections.
Discussion
Although some epidemiological studies suggest that
ultrafine particles have serious health effects [32-34], oth-
ers fail to prove that this PM fraction is more relevant to
Table 4: Summary of histological lung changes due to 2-day filtered air control or exposure to concentrated ambient particulate 
matter
uCAP (Site I) u+fCAP (Site II)
Parameter Control
(n = 40)
CAP
(n = 40)
Control
(n = 64)
CAP
(n = 64)
Alveolar macrophages
minimal 29 33 33 41
slight 0 3 2 2
Foci thick septa + 
macrophages
minimal 22 23 31 28
slight 2 0 2 5
Perivascular infiltrate 29 22 51 58
Foci interstitial pneumonia 
with alveolitis 
(macrophages + 
lymphocytes)
minimal 0 0 1 0
Peribronchitis+hypertroph
y bronchial epithelium
00 01
Macrophages loaded with 
Particulate matter
00 0 5 2
Erythrocytes in alveoli 28 24 41 39
BrdU score number 
examined
40 39 64 64
Minimal 27 28 39 35
Slight 1 0 5 4
BrdU, bromodeoxyuridine; CAP, concentrated ambient particulate matter;
LUC % 0.384 0.340–
0.427
0.391 0.339–
0.443
0.218 0.152–
0.285
0.254 0.190–
0.318
***
Fibrino
gen
mg/ml 2.18 2.13–
2.22
2.16 2.13–
2.19
2.236 2.199–
2.274
2.267 2.232–
2.303
b
vWF ratio 1.49 1.34–
1.65
1.64 1.36–
1.92
0.67 0.65–
0.70
0.65 0.61–
0.69
a
an = 32; bn = 61; cn = 63; *p < 0.05; **p < 0.01; ***p < 0.001. For abbreviations of the markers, see Materials and methods
Table 3: Health effect parameters measured in blood of spontaneously hypertensive rats 8 h after exposure to concentrated ambient 
particulate matter or clean air as a control. (Continued)Particle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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health than the fine fraction of PM [35,36], or they fail to separate the effects of ultrafine particles from other air
pollutants [37]. The present study focuses on the hypoth-
esis that the ultrafine fraction of PM2.5 dominates the
biological responses of rats [32,38,39]. Although there are
some small differences between repeated studies with
fCAP and u+fCAP, these studies do not fully support our
hypothesis.
Besides the normal pathological pulmonary characteris-
tics of the SH rat, no differences (including differences in
cell proliferation) were observed between the control rats
and the fCAP or u+fCAP exposed rats. However, in con-
trast to the animals exposed to fCAP (in which more than
half of the mass consists of sulphate, nitrate, and ammo-
nium), black particles appeared in the alveolar macro-
phages of the rats exposed to u+fCAP. This indicates that
significant amounts of insoluble particles were deposited
in the lungs. It is likely that they originated from combus-
tion processes. Since these exposures were carried out next
to a busy freeway, a substantial part of the pollution will
have been produced by traffic. Most of the biological end-
points were not affected at all, and the biological rele-
Clara cell secretory protein present in bronchoalveolar lav- age fluid after rats were exposed to fine, concentrated, ambi- ent particulate matter (fCAP) (site I)   control, ■  fCAP  exposed Figure 4
Clara cell secretory protein present in bronchoalveolar lav-
age fluid after rats were exposed to fine, concentrated, ambi-
ent particulate matter (fCAP) (site I)   control, ■  fCAP 
exposed.
Correlation between heme oxygenase-1 present in bronchoalveolar lavage fluid versus heme oxygenase-1 present in lung  homogenate Figure 3
Correlation between heme oxygenase-1 present in bronchoalveolar lavage fluid versus heme oxygenase-1 present in lung 
homogenate. All animals were exposed to fine, concentrated, ambient particulate matter. Regression: Y = -0.15 + 0.217*X, 
correlation coefficient = 0.79.Particle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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vance of markers that were influenced by CAP exposures
remains questionable. This is in line with a previous study
[27], in which fCAP (1-day exposures) produced little
effect in the bronchoalveolar lavage fluid of SH rats, with
the exception of an increase of PMNs.
We added two additional parameters for oxidative stress
to the present study: MDA as a measure of lipid peroxida-
tion and HO-1 as a measure of antioxidant response. An
increase of lipid peroxidation is expected after exposure to
air pollution with oxidative capacity, such as pollution by
ozone or PM containing polycyclic aromatic hydrocarbon
(PAH) and metals. However, exposure to CAP in the
present study resulted in either no significant change
(fCAP) or a significant decrease (u+fCAP) of MDA levels
in bronchiolar lavage fluid. The biological relevance of
these observations is questionable, given the smallness of
the decline. Inconsistent data regarding both humans and
rats have been reported both as increases [40,41] and
decreases [42] of lipid peroxidation after exposure to par-
ticles. Where the increase is often seen as a direct result of
the oxidative stress, the decrease is assigned to the adap-
tive capacity of the human organism after prolonged
exposure [42].
Exposure to fCAP (after omitting the two highest exposure
concentrations) or u+fCAP resulted in a significant
increase in HO-1. The enzyme HO-1 is regulated by oxi-
dative stress, catalysing heme oxidation into biliverdin,
CO, and iron. The increase results in augmented produc-
tion of the antioxidant biliverdin and CO, which acts as
an anti-inflammatory agent [43]. Indeed, the present
study finds no sign of developing inflammation. Various
agents, such as endotoxins, cytokines, and heavy metals,
as well as CO itself, are known to induce HO-1 [44,45].
The use of HO-1 as a biologically relevant indicator of
PM-induced stress has been exemplified in in vitro studies
in which the PAH content derived from airborne PM pos-
itively correlates with increased HO-1 expression [46,29].
It also has been proven that the oxidative potential of CAP
in in vitro studies correlate well with HO-1 induction [47].
In vitro studies that use a murine macrophage cell line
[47], have shown that ultrafine PM is a more potent
inducer of HO-1 and depleter of intracellular glutathione
(anti-oxidant) than ultrafine+fine PM. However, the
present study gives no clear indications that, per unit
mass, u+fCAP has a greater impact on HO-1 or glutath-
ione than fCAP. Although this might occur at higher expo-
sure levels for u+fCAP than were achieved in this study
(550 µg/m3), the oxidative stress potency as measured by
the HO-1 of ultrafine particles deposited in the lungs may
not be significantly greater than that of fine particles.
A statistically significant decrease of WBCs after exposure
to fCAP and u+fCAP was noted. There was a concomitant
decrease of absolute numbers of neutrophils and lym-
phocytes. It has previously been reported that these sys-
temic responses, such as a decrease in WBC, are observed
24 h after exposure [25], but not immediately after expo-
sure to CAP [25,26]. Ghio states that the extravasion of
neutrophils from the blood into the lung would account
for the time dependency of the decrement of the WBC
count, since an inflammatory influx after PM exposure is
not immediate, but certainly becomes evident at 24 h
[25]. However, others [48] report that haematological
changes (increase in blood neutrophils and a decrease in
lymphocytes 3 h after exposure of rats to CAP (3 h for
110–350 µg/m3), but these changes were absent at 24 h
after exposure. Such an increase in WBC counts purport-
edly reflects the inflammatory state after inhalation of PM.
In a study similar to ours, Kodavanti et al. [15] report that
there were no significant changes in haematological
parameters 18–20 h after exposure.
In contrast to previous findings [15,27], we do not
observe changes in plasma fibrinogen concentrations as a
result of exposure to both u+fCAP and fCAP. The fibrino-
gen concentration, a risk factor for cardiovascular disease,
has been shown to increase after PM exposure in rodent
studies [49-51] as well as in human studies [25,52],
although decreases have also been observed [49]. A strain-
dependent effect in the increase of fibrinogen has also
been observed: the effects seem more dominant in SH rats
than in Wistar-Kyoto (WKY) rats. This supports the
hypothesis that humans with cardiovascular diseases may
be more susceptible to increased pulmonary and cardiac
impairments [51,53]. A significant increase of fibrinogen
levels in SH rats (but not WKY rats) exposed to CAPs has
been found [15]. Sela et al [54] proved that oxidative
stress resulted in increased plasma MDA, fibrinogen, and
PMN counts before hypertension developed in the rat. In
this respect, the absence of increased serum fibrinogen
levels is rather unexpected. Differences in CAP composi-
tion might explain these differences.
The significant changes on the haematological indices cor-
puscular volume (increased MPV and decreased MCV) in
combination with unchanged platelet numbers found
after exposure to u+fCAP suggests that the ultrafine parti-
cles might have effects on the platelet state. These observa-
tions are therefore in agreement with the hypothesis that
PM can affect haematological indices [55]. It has been
observed that a reduction of MPC may be used to detect in
vitro platelet activation [56]. However, since the observed
differences are very small and opposite in sign, it is ques-
tionable whether the changes are biologically relevant.
The fact is that u+fCAP contains less of the soluble inor-
ganic aerosols, sulphates, nitrates, and ammonium than
fCAP. Indeed, u+fCAP is very likely to be enriched withParticle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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carbonaceous (combustion derived) PM since these expo-
sures took place right next to a traffic tunnel. However,
except for the black particles in the lung tissue and the
changed haematological parameters concerning the plate-
let state, the effects observed for the fCAP and u+fCAP
exposures do not differ.
Studies using concentrated PM are confronted with the
fact that air pollution is a complex mixture that varies
from day to day. As a consequence, duplication of experi-
ments is virtually impossible. Epidemiological studies
have consistently demonstrated that health effects can be
predicted with monotonic functions of particle mass con-
centrations. In turn, CAP studies can be used to verify this
relationship under more controlled conditions. In other
words, this allows for testing the hypothesis that effects on
biological systems due to exposure to PM are always line-
arly related to the mass concentration. However, the
results of the present study indicate that, for example, HO-
1 levels show a significant nonlinear relationship with
particle mass concentrations. Similar response patterns
were seen for CC16 in lavage fluid. In both cases, com-
bined analysis of all experiments did not reveal a statisti-
cally significant effect due to CAP exposures. Some other
studies report that linear regression shows correlations
between a biomarker and the exposure concentrations
[27,18,28], but the correlations are usually rather poor.
Unfortunately, many of the other markers of biological
effect in the present study were not affected at all, which
precluded a similar analysis. Therefore, analysis of the
combined data of multiple CAPs experiments should
always consider that nonmonotonic relationships of con-
centration effects may be better descriptors of physiologi-
cal processes. The phenomenon of nonmonotonic
relationships of concentration effects applies to many bio-
logical processes, for example, enzymatic activity as a
function of temperature.
The results of the present series of experiments indicate
that minor pulmonary and systemic effects are due to
exposure to fine and ultrafine+fine particles at concentra-
tions well above ambient levels. No clear CAP mass corre-
lation has been found for these effects based on the
assumption that this relation is linear as shown in epide-
miological studies. We even provide evidence that effects
due to the oxidative potential of PM might be masked at
greater than ambient concentrations, so that prudence is
called for when sets of exposures of various concentra-
tions are combined in order to increase the group number
of observations in a statistical analysis. In addition, this
study shows no proof that change of location, resulting in
a larger traffic CAP component, results in noteworthy and
biological relevant pulmonary or systemic effects.
Materials and methods
Animals
Male SH rats, 11–13 weeks old, were purchased from
Charles River Laboratories were assigned to 13 studies
(Table 1). Immediately after arrival, the animals were
weighed, randomized and then allowed to acclimatize for
at least 7 days. The animals were housed in macrolon
cages (type III) and fed with SSP-TOX pellets of a cereal-
based rodent diet (SMR-A; Hope Farms, Woerden, the
Netherlands) and tap water via the automatic drinking-
water system, both ad libitum during nonexposure peri-
ods. The room temperature was maintained at 22 ± 2°C,
the relative humidity at 40–70%, and a 12-h light/dark
cycle was maintained.
Each study used eight animals for CAP exposure and eight
animals for filtered air exposure (control group). Shortly
before exposure, the animals were transported to the
mobile exposure laboratory equipped with an ambient
particle concentrator, where they were housed in macro-
lon type III cages, equipped with water bottles. The hous-
ing facilities were ventilated with HEPA filters and
chemically (activated carbon and purafil) filtered air.
Directly after the animals were exposed to CAP or clean air
(which was done simultaneously), they were returned to
the housing facilities. During exposure, the animals were
deprived of water and food.
Study design
A total of 13 studies (which were identical apart from the
CAP exposure) were performed at two locations. The SH
rats were either exposed to fCAP (five replicate studies
located in a city background in Bilthoven = site I) or to
u+fCAP (eight replicate studies located in a freeway tunnel
near Hendrik Ido Ambacht (HIA; site II)). Each study con-
sisted of a control group of eight animals exposed to
HEPA-filtered air, and a group of eight animals exposed to
CAP. Exposures lasted 6 h on 2 consecutive days (Figure
1).
Generation and characterization of the test atmosphere
To obtain fCAP, ambient PM was generated by drawing
ambient air through a size selective inlet that removes par-
ticles larger than 2.5 µm and subsequently through a four-
stage set-up of the ambient fine particle concentrator
(AFPC) [11]. The AFPC operates at an air-intake rate of
5000 l/min, and the output flow for PM is 10 l/min. The
size distribution of the ambient aerosol after the air
passed the PM2.5 size selective inlet was determined dur-
ing the exposure period with a multi-orifice-impactor
(MOI, MSP, Minneapolis, Minn., USA).
The PM mass concentrations were measured continuously
at the inlet (ambient) and once an hour (for 5 min) at the
outlet of a concentrator during the exposure with a neph-Particle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
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elometer (DATARAM, MIE, Billerica, Mass., USA). The
time-integrated mass concentrations were also measured
at both the inlet and the outlet by means of collection on
two 47-mm filters placed in parallel (polytetrafluoroeth-
ylene (PTFE) and Quartz), with sampling at a flow rate of
2 l/min. Ozone, carbon monoxide, sulphur dioxide,
nitrogen oxides, and the particle number concentrations
were recorded every minute in the ambient air behind the
PM2.5 impactor. The size distribution of the concentrated
aerosol in the range of 0.15 – 2.5 µm was determined
once an hour with an aerodynamic particle sizer for parti-
cles greater than 0.5 µm (APS, TSI, St. Paul, Minn., USA).
The u+fCAP exposure atmospheres were generated by
drawing ambient air through a modified single-stage set-
up of a versatile aerosol concentration enrichment system
(VACES) [12,13]. The design of the VACES is such that
particles greater than 2.5 µm are not concentrated. The
VACES operates at an air intake flow rate of 500 l/min,
and the output flow for PM is 15 l/min. The temperature
of the coolers was kept at a constant -4°C. The tempera-
ture of the humidifiers was kept between 25°C and 30°C,
depending on the ambient air conditions. The size distri-
bution of the concentrated aerosol in the range of 0.01µm
-2.5 µm was determined once an hour with an aerody-
namic particle sizer (particles >0.5 µm) (APS, TSI, St. Paul,
Minn., USA) for the fCAP experiments.
A condensation particle counter (CPC, TSI, St. Paul,
Minn., USA) was used to determine the particle number
concentrations after the particles had passed through the
concentrator. PM was collected on three 47-mm filters (2
× PTFE and 1 × Quartz) placed in parallel at flow rate of
10 l/min. Similar, PM was collected at a flow rate of 1 l/
min after the air passed the concentrator. A carbon sam-
pler tube was placed downstream of one of the PTFE filters
at the outlet to collect the VOCs. Ozone, carbon monox-
ide, sulphur dioxide, nitrogen oxides, and the particle
number concentrations were recorded every minute in the
ambient air upstream of the humidifier impactor. The size
distribution of the concentrated aerosol in the range of
0.02 – 2.5 µm was determined once an hour with an aer-
odynamic particle sizer (for particles >0.5 µm) (APS, TSI,
St. Paul, Minn., USA).
Temperature and relative humidity was recorded once
every 5 minutes in the exposure chambers and control
exposure chambers, as well as in the ambient air during
the exposures. A Sartorius MC-5 microbalance (Sartorius,
Goettingen, Germany) was used in controlled relative
humidity (40 – 45%) and temperature (22 – 24°C) con-
ditions to do the mass measurements, and the PTFE filters
were weighed before and after each field test. Laboratory
and field blanks were used for quality assurance. We then
analysed the PTFE filters by means of ion chromatography
to determine the concentrations of particulate sulphate,
nitrate, and ammonium ions. The Quartz filters and acti-
vated carbon samplers were stored for future use. At this
stage, no efforts have been made for chemical characteri-
zation of the PM samples since hardly any effect due to
CAP exposure was observed.
Exposure chamber
Rats were exposed to the test atmosphere in a nose-only
exposure chamber placed inside an inhalation unit, which
was lighted with tubular fluorescent lamps. The animals
were placed in nose-only tubes (Novoplast Tube T, Mün-
ster, Muttenz, Switzerland), restrained, and attached to
the exposure chamber. The animals could breathe a con-
tinuous supply of test atmosphere during exposure (about
8 l/min). Control groups were exposed to air drawn from
a concentrator down stream to the size selective inlet, and
a HEPA filter filtered the air to provide a particle-free
exposure atmosphere. To minimize stress, the animals
were allowed to become accustomed to the tubes for 3
days in advance of the exposure, 1 h each day without
exposure to the test atmosphere.
Necropsy
Eighteen hours after exposure, the rats were anaesthetized
with Ketamine/Rompun (0.1 ml/100 g body weight of a
mix of 0.85 ml 100 mg/ml Ketamine (Aesculaap, Boxtel,
The Netherlands) and 0.65 ml of 20 mg/ml Rompun
(Bayer, Leverkusen, Germany) and sacrificed by exsan-
guination via the abdominal aorta. A cannula was inserted
in the trachea, and bronchoalveolar lavage fluid (BALF)
was taken from the right lung after ligation of the left
bronchus. The right lungs were lavaged (three times up
and down) with a volume of saline corresponding with 27
ml/kg body weight at 37°C. The fluid recovered from the
lavage was placed on ice. The left lung was dissected,
weighed, and fixed for 1 h under a constant pressure of 20
cm H2O with 10% phosphate-buffered formalin. Five µm
paraplast lung sections were stained with haematoxylin
and eosin (H&E) and examined under a light microscope.
Morphometry
To measure cumulative cell proliferation, the animals
were injected prior to CAPs exposure and 2 h prior to
necropsy with bromodeoxyuridine (BrdU) measured
to100 mg/kg body weight (Sigma-Aldrich, Zwijndrecht,
The Netherlands). Lung sections from these animals were
immunohistochemically stained with anti-BrdU antibody
(Boehringer, Mannheim, Germany) and labelled with
peroxidase. Since only the inflammatory foci displayed a
focally increased proliferation rate, only a semi quantita-
tive labelling score for the size of areas with an increased
labelling was assigned. Labelling the frequency in square
millimetres of bronchiolar epithelium, for example,
makes no sense, as this procedure is fully dependant onParticle and Fibre Toxicology 2006, 3:7 http://www.particleandfibretoxicology.com/content/3/1/7
Page 12 of 14
(page number not for citation purposes)
how much epithelium is measured both inside and out-
side an inflammatory focus.
The analySIS soft imaging system (SIS, Münster, Ger-
many) was used to quantify the BrdU-stained cells per
millimetre of terminal bronchiolar epithelium. Terminal
bronchioles were defined as those bronchioles flowing
into alveolar ducts, as well as bronchioles smaller than
250 µm in diameter that are situated in the periphery of
the lung and in the close vicinity of a centriacinar area.
The total length of examined terminal bronchioles per
animal varied between 15 mm and 25 mm.
Bronchoalveolar lavage analyses
The BALF collected from each animal was centrifuged at
400 g and 4°C for 10 min. The cell-free fluid from the lav-
age was used for biochemical assays. We used a commer-
cial reagent kit (Roche Nederland, Mijdrecht, The
Netherlands) to determine the activities of lactate dehy-
drogenase (LDH), N-acetyl glucosaminidase (NAG), alka-
line phosphatase (ALP). The levels of uric acid (UA-B)
were determined using a reagent kit obtained from Roche
(Almere, the Netherlands) and malondialdehyde (MDA)
was determined using a HPLC kit obtained from Chrom-
systems (Munich, Germany). We determined the total
protein levels with a reagent kit obtained from Pierce
(Oud-Beijerland, The Netherlands). Methods for the
determination of glutathione, both its reduced (GSH) and
oxidized (GSSG) forms, and Clara cell secretory protein
(CC16) have been described previously [27].
We determined the total cell number by mixing 0.5 ml of
the cell suspension with 9.5 ml of Isoton II (Beckman
Coulter, Mijdrecht, The Netherlands) and then counting
them in a Coulter Counter Z1 and Z2 (Beckman Coulter,
Mijdrecht, The Netherlands). For differential cell counts,
cytospin preparations were made and stained with the
May-Grünwald and Giemsa method. Each cytospin prep-
aration counted 400 cells, and the proportion of each cell
type (macrophages, neutrophilic granulocytes, eosi-
nophilic granulocytes, and lymphocytes) was calculated
on the basis of total cells per BALF sample.
Blood analysis
Fibrinogen was determined as a risk factor for thrombotic
vascular disorder and von Willibrand factor (vWf) as a
marker for early endothelial injury, both as previously
described [27].
Cell differentials were determined in ethylenediamine-
tetraacetic acid (EDTA; Terumo Europe, Leuven, Bel-
gium), and anticoagulated blood was analysed in an H1-
E Multi Species Haematology Analyser (Bayer, Mijdrecht,
The Netherlands). The following parameters were meas-
ured: white blood cell (WBC) and red blood cell (RBC)
concentrations, haemoglobin (HGB) and platelet concen-
trations (PLT), the mean platelet volume (MPV), and the
haematocrit value (HCT). The mean corpuscular volume
(MCV), mean platelet component (MPC), mean cell hae-
moglobin (MCH), mean cell haemoglobin concentration
(MCHC), red blood cell distribution width (RDW) and
haemoglobin distribution width (HDW) are also pro-
vided.
Statistical analysis
All effect parameters were log-transformed before two-
way analysis of variance (ANOVA) was performed. Log-
transformation is used to account for the increased varia-
tion in groups of animals exposed to CAPs versus the ani-
mals that were sham exposed. Two-way ANOVA
techniques (simple factorial) were used to assess differ-
ences due to the factors "CAP exposure", "day-to-day var-
iation" and their interaction while treating "CAP
exposure" as a binary term. For those biological parame-
ters that showed a significant effect of "CAP exposure" fac-
tor between control animals and CAP-exposed animals,
the binary exposure factor was replaced by particle mass
CAP as a continuous grouping factor, after which another
two-way ANOVA and univariate regression analysis were
performed. S-Plus software was used for all statistical anal-
yses. The criterion for significance was set at p < 0.05.
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